biological activity | Bohemine is a CDK inhibitor, the IC50 values for Cdk2/cyclin A and Cdk9/cyclin T1 were 4.6, 83 and 2.7 μm, respectively. |
Target | Value |
Cdk9/cyclin T1
()
| 2.7 μM |
Cdk2/cyclin E
()
| 4.6 μM |
Cdk2/cyclin A
()
| 83 μM |
Cell Line:
| Mouse hybridoma ME-750 cells |
Concentration:
| 0 µM, 1 µM, 3 µM, 10 µM and 30 µM |
Incubation Time:
| 72 hours |
Result:
| At 10 µM and 30 µM concentrations, the viable cell count was significantly lower with respect to control, i.e., 77% and 48%, respectively. C max is 72,308 nM, observed clearance is 0.23 L/h and T 1/2 is 1.39 h. |
Animal Model:
| BALB/c mice bearing the colon 26 murine tumor |
Dosage:
| 50 mg/kg |
Administration:
| Intravenous injection (Pharmacokinetic Analysis) |